24小时热门版块排行榜

返回列表

slimdell

金虫 (初入文坛)

应助: 7 (幼儿园)
金币: 1470.2
帖子: 38
在线: 15.9小时
虫号: 97779

[资源] 职业发展白皮书- The continuing evolution of the Pharmaceutical Industry

RegentAtlantic Capital, LLC is pleased to present our white paper entitled “The Continuing Evolution of the Pharmaceutical Industry: Career Challenges and Opportunities”.

http://www.pharmawealthmanager.c ... Y%20Nov-30-2007.pdf

The Continuing Evolution of the
Pharmaceutical Industry:
Career Challenges and Opportunities
December 2007

Michael Steiner, CFP®, CPA
David H. Bugen, CFP®, MBA
Brian Kazanchy, CFP®, CFA, MBA
William T. Knox IV, CFP®, CFA, JD
Margaret V. Prentice, MBA
Lauren Goldfarb
Mark P. Hurley
Steven E. Cortez
Christine L. Boudreaux
Benjamin J. Robins
Yvonne N. Kanner
Shehzad Sippy
Adam L. Bartkoski
Ana M. Avila

are Changing the Industry and the
Careers of its Participants ............................................................. 3
Revenues are Under Pressure ................................................. 3
Costs and Risks of Developing New Drugs are Increasing ....... 3
Globalization ............................................................................ 4
Big Changes for the Pharmaceutical Industry .................................. 4
Corporate Restructuring .......................................................... 5
Adoption of Risk Reduction Strategies ..................................... 5
Evolution of Drug Marketing ..................................................... 6
What Does it all Mean to an Industry Professional? .......................... 6
Six Future High Growth Areas of the Industry .................................. 6
Commercialization of Dormant Compounds ............................ 7
Generic or Biosimilar Versions of Biologics .............................. 7
Improving the Effi ciency of R&D ............................................... 7
Oncology and Central Nervous System (CNS)
Disorders Research ......................................................... 7
Stratifi ed Medicine and Diagnostics ......................................... 7
Fusion of Pharmaceuticals and Consumer Goods ................... 8
Seven Highly-Valued Skill Sets ......................................................... 8
Ability to Manage Decentralized Intellectual Capital Resources .....8
Ability to Work in Joint Ventures and Across Divisions,
Cultures and Countries.................................................... 8
Ability to Integrate an Understanding of Intellectual
Property Laws, Scientifi c Expertise
and Business Strategy ..................................................... 9
Ability to Spur Creativity While Managing Commercially ........... 9
Knowledge and Insight on the Decision-Making
Dynamics of Payers ........................................................ 9
Expertise in the Functioning and Decision-Making
of Regulatory Agencies ................................................. 10
Human Resource Skills to Help Transform Pharmaceutical
Companies ................................................................... 10
Every Industry Participant will Experience Change ......................... 10
Conclusion .................................................................................... 11
II. An Industry Forced to Change ................................ 12
Forces Shaping the Pharmaceutical Industry ................................. 12
Industry Revenues are Under Pressure .................................. 12
Costs and Risks are Increasing .............................................. 23
Globalization .......................................................................... 27
Big Changes for the Pharmaceutical Industry ................................ 30
Limited and Unattractive Choices .......................................... 30
Changes Have Already Begun ............................................... 31
Dislocation of a Generation of Upper-Middle and
Senior-Level Executives ................................................. 32
Mergers and Acquisitions as a Cost-Cutting Strategy ............ 33
Refocused Strategies with Fewer Treatment Lines ................. 35
Acquiring Instead of Developing Compounds ........................ 36
Research Consortiums Share Risk ......................................... 37
Outsourcing of R&D to Foreign Laboratories .......................... 38
Evolution of Marketing ........................................................... 38
A Very Different Industry ................................................................ 40
III. Opportunities for the Next Decade ......................... 42
A New Golden Era ......................................................................... 42
Six High-Growth Areas .................................................................. 43
Commercialization of Dormant Compounds .......................... 43
Generic or Biosimilar Versions of Biologics ............................ 44
Improving the Effi ciency of R&D ............................................. 47
Oncology and Central Nervous System (CNS)
Disorders Research ....................................................... 48
Stratifi ed Medicine and Diagnostics ....................................... 50
Fusion of Pharmaceuticals and Consumer Goods ................. 51
Seven Skill Sets with Great Future Value ........................................ 52
Ability to Manage Decentralized Intellectual
Capital Resources .......................................................... 52
Ability to Work in Joint Ventures and Across Divisions,
Cultures and Countries.................................................. 53
Ability to Integrate an Understanding of Intellectual
Property Laws, Scientifi c Expertise and
Business Strategy ................................................... 54
Ability to Spur Creativity While Managing Commercially ......... 55
Knowledge and Insight on the Decision-Making Dynamics
of Payers ....................................................................... 57
Expertise in the Functioning and Decision-Making of
Regulatory Agencies ..................................................... 58
Human Resource Skills to Help Transform Pharmaceutical
Companies ................................................................... 59
IV. Planning Your Future ................................................ 60
Step 1: Taking Responsibility for Your Career Planning .................. 60
Step 2: Assessing the Industry’s Future Structure
and Your Tolerance for Risk ........................................................ 61
The Shifting Structure of the Pharmaceutical Industry ............ 61
Cultures Vary by Size of Enterprise ........................................ 62
The Risk vs. Reward Calculus ................................................ 65
Step 3: Evaluating Your Financial Resources and the
Economic Impact of a Career Change ........................................ 67
Evaluating Your Asset Allocation and the Concentration Risk
Borne by Many in the Pharmaceutical Industry .............. 69
Leaving an Employer Will Often Involve Hidden Costs ............ 72
Understanding Risks Involved in Taking a New Job ................ 77
Step 4: Figuring Out Who You Are and How to Brand Yourself ...... 82
Athletes vs. Specialists .......................................................... 82
Developing a Personal Branding Strategy .............................. 84
A Final Thought: Begin with a Comprehensive Self-Assessment .... 86
V. Conclusion ................................................................ 87
VI. Appendix.................................................................... 88

回复此楼